Phospho-NF2 (S518) Polyclonal Antibody, 100 µg, (ATB-P0180)

Description

Background:

Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity. Suppresses cell proliferation and tumorigenesis by inhibiting the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.

Product datasheet:

References:

1. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.
   Trofatter J.A., Maccollin M.M., Rutter J.L., Murrell J.R., Duyao M.P., Parry D.N., Eldridge R., Kley N., Menon A.G., Pulaski K., Haase V.H., Ambrose C.M., Munroe D., Bove C., Haines J.L., Martuza R.L., Macdonald M.E., Seizinger B.R.
   , Short M.P., Buckler A.J., Gusella J.F.
   Cell 72:791-800(1993) [PubMed] [Europe PMC]

   Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).

2. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
   Rouleau G.A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B., Pulst S., Lenoir G., Bijlsma E., Fashold R., Dumanski J.P., de Jong P., Parry D., Eldrige R.
   , Aurias A., Delattre O., Thomas G.
   Nature 363:515-521(1993) [PubMed] [Europe PMC]

   Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].

3. NF2 gene in neurofibromatosis type 2 patients.
   Zucman-Rossi J., Legoix P., Der Sarjussian H., Cheret G., Sor F., Bernardi A., Cazes L., Giraud S., Lenoir G., Thomas G.
   Hum. Mol. Genet. 7:2095-2101(1998) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
4. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules.
   Schmucker B., Tang Y., Kressel M.
   Hum. Mol. Genet. 8:1561-1570(1999) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 7; 9 AND 10), SUBCELLULAR LOCATION.
5. Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts.
   Chang L.-S., Akhmametyeva E.M., Wu Y., Zhu L., Welling D.B.
   Genomics 79:63-76(2002) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3; 4; 5; 6 AND 8).
6. A genome annotation-driven approach to cloning the human ORFeome.
   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A., Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J., Beare D.M., Dunham I.
   Genome Biol. 5:R84.1-R84.11(2004) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
7. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
   The MGC Project Team
   Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4). Tissue: Lung and Skin.
8. The gene of neurofibromatosis type 2.
   Marineau C., Merel P., Rouleau G.A., Thomas G.
   Medecine/Sciences 11:35-42(1995)Cited for: REVIEW.
9. NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins.
   Murthy A., Gonzalez-Agosti C., Cordero E., Pinney D., Candia C., Solomon F., Gusella J., Ramesh V.
   J. Biol. Chem. 273:1273-1276(1998) [PubMed] [Europe PMC] Cited for: INTERACTION WITH SLC9A3R1.
10. The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate.
    Scoles D.R., Huynh D.P., Chen M.S., Burke S.P., Gutmann D.H., Pulst S.-M.
    Hum. Mol. Genet. 9:1567-1574(2000) [PubMed] [Europe PMC] Cited for: INTERACTION WITH HGS.